GT
AGN

Glenmede Trust’s Allergan plc AGN Stock Holding History

Glenmede Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,940
Closed -$1.9M – 2746
2020
Q1 		$1.9M Hold
9,940
– – 0.01% 629
2019
Q4 		$1.9M Sell
9,940
-1,134
-10% -$205K 0.01% 629
2019
Q3 		$1.86K Sell
11,074
-15,774
-59% -$2.57M 0.01% 632
2019
Q2 		$4.49K Buy
26,848
+17,934
+201% +$2.48M 0.02% 491
2019
Q1 		$1.3K Sell
8,914
-3,170
-26% -$460K 0.01% 699
2018
Q4 		$1.61K Buy
12,084
+7,047
+140% +$1.16M 0.01% 653
2018
Q3 		$958K Buy
5,037
+8
+0.2% +$1.47K ﹤0.01% 755
2018
Q2 		$839K Sell
5,029
-924
-16% -$148K ﹤0.01% 741
2018
Q1 		$973K Hold
5,953
– – ﹤0.01% 783
2017
Q4 		$973K Buy
5,953
+89
+2% +$16K ﹤0.01% 783
2017
Q3 		$1.2M Buy
+5,864
New +$1.36M 0.01% 730
2017
Q1 		– Sell
-5,883
Closed -$1.23M – 2797
2016
Q4 		$1.23M Sell
5,883
-4,347
-42% -$901K 0.01% 711
2016
Q3 		$2.35M Sell
10,230
-849
-8% -$207K 0.01% 593
2016
Q2 		$2.56M Buy
11,079
+2,260
+26% +$521K 0.02% 570
2016
Q1 		$2.36M Sell
8,819
-7,824
-47% -$2.24M 0.02% 576
2015
Q4 		$5.2M Sell
16,643
-6,672
-29% -$1.99M 0.04% 436
2015
Q3 		$6.34M Sell
23,315
-4,138
-15% -$1.27M 0.05% 379
2015
Q2 		$8.33M Sell
27,453
-100,059
-78% -$29.8M 0.06% 368
2015
Q1 		$37.9M Buy
127,512
+76,043
+148% +$21.7M 0.28% 90
2014
Q4 		$13.2M Buy
51,469
+3,448
+7% +$862K 0.1% 293
2014
Q3 		$11.6M Buy
48,021
+29,547
+160% +$6.61M 0.1% 289
2014
Q2 		$4.12M Sell
18,474
-3,008
-14% -$623K 0.04% 429
2014
Q1 		$4.42M Sell
21,482
-3,677
-15% -$728K 0.04% 418
2013
Q4 		$4.22M Sell
25,159
-1,381
-5% -$216K 0.04% 413
2013
Q3 		$3.82M Sell
26,540
-9,070
-25% -$1.21M 0.05% 412
2013
Q2 		$4.49M Buy
+35,610
New +$4.03M 0.06% 351

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Glenmede Trust's AGN Position: Q2 2020 in Review

Glenmede Trust sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,940 shares — an estimated $1.9M sold.

Glenmede Trust first reported a position in AGN in Q2 2013 and held it in 26 quarters. The position peaked at $37.9M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Glenmede Trust reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Glenmede Trust sold 9,940 Allergan plc shares in Q2 2020, an estimated $1.9M.
  • Glenmede Trust first reported a position in Allergan plc in Q2 2013 and held it in 26 quarters.
  • Glenmede Trust's Allergan plc position peaked at $37.9M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.